Title
Glycated haemoglobin (HbA1c) and fasting plasma glucose relationships in sea-level and high-altitude settings
Date Issued
01 June 2017
Access level
open access
Resource Type
journal article
Author(s)
Pillay T.D.
Smeeth L.
Checkley W.
Publisher(s)
Blackwell Publishing Ltd
Abstract
Aim: Higher haemoglobin levels and differences in glucose metabolism have been reported among high-altitude residents, which may influence the diagnostic performance of HbA1c. This study explores the relationship between HbA1c and fasting plasma glucose (FPG) in populations living at sea level and at an altitude of > 3000 m. Methods: Data from 3613 Peruvian adults without a known diagnosis of diabetes from sea-level and high-altitude settings were evaluated. Linear, quadratic and cubic regression models were performed adjusting for potential confounders. Receiver operating characteristic (ROC) curves were constructed and concordance between HbA1c and FPG was assessed using a Kappa index. Results: At sea level and high altitude, means were 13.5 and 16.7 g/dl (P > 0.05) for haemoglobin level; 41 and 40 mmol/mol (5.9% and 5.8%; P < 0.01) for HbA1c; and 5.8 and 5.1 mmol/l (105 and 91.3 mg/dl; P < 0.001) for FPG, respectively. The adjusted relationship between HbA1c and FPG was quadratic at sea level and linear at high altitude. Adjusted models showed that, to predict an HbA1c value of 48 mmol/mol (6.5%), the corresponding mean FPG values at sea level and high altitude were 6.6 and 14.8 mmol/l (120 and 266 mg/dl), respectively. An HbA1c cut-off of 48 mmol/mol (6.5%) had a sensitivity for high FPG of 87.3% (95% confidence interval (95% CI) 76.5 to 94.4) at sea level and 40.9% (95% CI 20.7 to 63.6) at high altitude. Conclusion: The relationship between HbA1c and FPG is less clear at high altitude than at sea level. Caution is warranted when using HbA1c to diagnose diabetes mellitus in this setting.
Start page
804
End page
812
Volume
34
Issue
6
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Scopus EID
2-s2.0-85019252258
PubMed ID
Source
Diabetic Medicine
ISSN of the container
07423071
Sponsor(s)
We would like to thank Ian Bennett, Fabiola León-Velarde and Miguel Villanueva for their useful and insightful comments to earlier drafts of this manuscript. Our gratitude is extended to all fieldworkers and participants for making this study possible. Members of the PERU MIGRANT Study Group: Antonio Bernabé-Ortiz, Lilia Cabrera, Héctor H. García, Robert H. Gilman, J. Jaime Miranda, Julio A. Poterico, Renato Quispe, Candice Romero, Juan F. Sánchez, Liam Smeeth. Members of the CRONICAS Cohort Study Group (in alphabetic order): Cardiovascular Disease: Antonio Bernabé-Ortiz, Juan P. Casas, George Davey Smith, Shah Ebrahim, Raúl Gamboa (R.I.P.), Héctor H. García, Robert H. Gilman, Luis Huicho, Germán Málaga, J. Jaime Miranda, Víctor M. Montori, Liam Smeeth; Chronic Obstructive Pulmonary Disease: William Checkley, Gregory B. Diette, Robert H. Gilman, Luis Huicho, Fabiola León-Velarde, María Rivera, Robert A. Wise; Training & Capacity Building: William Checkley, Héctor H. García, Robert H. Gilman, J. Jaime Miranda, Katherine Sacksteder. The PERU MIGRANT Study data are publicly available at: https://figshare.com/articles/PERU_MIGRANT_Study_Baseline_dataset/3125005. The CRONICAS Cohort Study data will be available at NHLBI's open repository (https://biolincc.nhlbi.nih.gov/home/). JJM and GM conceived the original idea. JCBA led the statistical analysis. RQ, TDP and JCBA wrote the first draft of the manuscript. ABO, WC and JJM aided with conceptualizing the study and edited/reviewed the manuscript. GM supervised analytical work, provided clinical feedback and edited/reviewed the manuscript. LS and RHG also provided critical inputs to earlier versions of the manuscript.
Sources of information:
Directorio de Producción Científica
Scopus